Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc

Bullboard Posts

Comment by JamesNeven1983on Oct 30, 2019 11:48pm

29 Views

Post# 30289969

RE:RE:RE:RE:RE:RE:RE:RE:RE:KLY IS GOING OUT OF BUSINESS

This is what you call fake news everyone the mental midget that loves to comment. I sadly dont have anything in the private placement. I just own ordinary shares of Kalytera.. thats because I actually have a life and responsibilities like owning a home etc that comes first. Not a life of 24/7 stockhouse board fapping you do. Sad and highly disturbing. Want to make a bet mental midget? Will you be gone by end of november if it does not drop at 0.01 or "fold" which you toute so much. You got schizophrenic syndrome or something? Come on mental midget stop yelling, i know you are highly frustrated. Extremely sad.

Bullboard Posts

BlackBerry’s cost-cutting yields Q1 2024 savings